Are you Dr. Slifman?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 25 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3924 Sw 57th Ave
Portland, OR 97221Phone+1 503-244-4280- Is this information wrong?
Summary
- Dr. Nancy Slifman, MD is a dermatologist in Portland, Oregon. She is currently licensed to practice medicine in Oregon, Ohio, and Massachusetts.
Education & Training
- Washington University/B-JH/SLCH ConsortiumResidency, Dermatology, 1988 - 1991
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Allergy and Immunology, 1985 - 1987
- Massachusetts General Hospital/Beth Israel Deaconess Medical Center/Brigham and Women's HospResidency, Dermatology, 1982 - 1984
- Oregon Health & Science University Public Health and General Preventive MedicineFellowship, Public Health and General Preventive Medicine, 1978 - 1980
- University of RochesterResidency, Pediatrics, 1976 - 1977
- University of Texas Southwestern Medical Center/Children's HealthInternship, Transitional Year, 1974 - 1975
- Tufts University School of MedicineClass of 1974
Certifications & Licensure
- OR State Medical License 1978 - 2024
- MA State Medical License 1976 - 2015
- OH State Medical License 1982 - 1982
- American Board of Pediatrics Pediatrics
Publications & Presentations
PubMed
- 155 citationsLeukocytoclastic vasculitis associated with tumor necrosis factor-alpha blocking agents.Niveditha Mohan, Evelyne T. Edwards, Thomas R. Cupps, Nancy R. Slifman, Jong-Hoon Lee, Jeffrey Siegel, M. Miles Braun> ;The Journal of Rheumatology. 2004 Oct 1
- 302 citationsListeria monocytogenes infection as a complication of treatment with tumor necrosis factor alpha-neutralizing agents.Nancy R. Slifman, Sharon K. Gershon, Jong-Hoon Lee, Evelyne T. Edwards, M. Miles Braun> ;Arthritis and Rheumatism. 2003 Feb 1
- 340 citationsLife-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept.Jong-Hoon Lee, Nancy R. Slifman, Sharon K. Gershon, Evelyne T. Edwards, William D. Schwieterman, Jeffrey Siegel, Robert P. Wise, S. Lori Brown, John N. Udall, M. Miles...> ;Arthritis and Rheumatism. 2002 Oct 1
- Join now to see all